(EMEM, Corning cellgro, Cat# 10–009-CV) containing 10% fetal calf serum
(FCS), 100 U/mL penicillin and 100 mg/mL streptomycin as described
previously1 (link). Primary
rat aortic fibroblasts (Cellbiologics, Cat# RA-6075) were cultured in
Dulbecco’s Modified Eagle’s Medium (DMEM, Corning cellgro, Cat#
10–017-CV) containing 10% fetal calf serum (FCS), 100 U/mL penicillin and
100 mg/mL streptomycin.
Adenovirus transductions were performed with ViraDuctin (Cell Biolabs,
Cat# AD-201) according to manufacturer protocol. Adenoviruses encoding PTEN
(Vector Biolabs, Cat# 1547) and GFP (Vector Biolabs, Cat# 1060) were used at 50
MOI for gene overexpression. Cell were rinsed with HBSS (Corning cellgro, Cat#
21–021-CV) 24 hours after the transduction and maintained in media with
10% FCS for 48 hours before switching to low serum media (0.1% FCS) for 48
hours. AngII or solvent (saline) were added to the cells without media change to
the final concentration of 100nM for 3 hours.
Pharmacological induction of PTEN expression was performed with
5-azacytidine (5-aza, Sigma-Aldrich, Cat# A2385). SMCs were allowed to attach in
EMEM with 10% FCS for 24 hours before switching to low serum media for 24 hours.
5-aza pre-treatment was performed in EMEM with 1% FBS at final concentration of
10μM for 24 hours before AngII/solvent treatment.